Serum proteomic profiling in patients with drug-induced liver injury Public Deposited

Analytics

Downloadable Content

Download PDF
Request Accessible Version
Creator
  • Bell, L. N.
    • Other Affiliation: Indiana University-Purdue University Indianapolis
  • Vuppalanchi, R.
    • Other Affiliation: Indiana University-Purdue University Indianapolis
  • Watkins, P. B.
    • Affiliation: University of North Carolina at Chapel Hill
  • Bonkovsky, H. L.
    • Affiliation: University of North Carolina at Chapel Hill
    • Other Affiliation: Carolinas Medical Center
  • Serrano, J.
    • Other Affiliation: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Fontana, R. J.
    • Other Affiliation: University of Michigan, Ann Arbor
  • Wang, M.
    • Other Affiliation: Indiana University-Purdue University Indianapolis
  • Rochon, J.
    • Other Affiliation: Duke Clinical Research Institute
  • Chalasani, N.
    • Other Affiliation: Indiana University-Purdue University Indianapolis
Abstract
  • Idiosyncratic drug-induced liver injury (DILI) is a complex disorder that is difficult to predict, diagnose and treat.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Journal title
  • Alimentary Pharmacology & Therapeutics
Journal volume
  • 35
Journal issue
  • 5
Page start
  • 600
Page end
  • 612
Language
  • English
ISSN
  • 1365-2036
  • 0269-2813
Parents:

This work has no parents.

Items

Thumbnail Title Date Uploaded Visibility Actions
EuropePMC-PMC3654532.pdf 2020-10-29 Public